Search

everythinglearnresearchcommunity

for

Search:↓

The combined therapy was effective and safe for children with severe alopecia areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

New alopecia treatments aim for better results and fewer side effects.

Hydroxychloroquine may help treat alopecia areata in children.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

Over 30% of livestock in New Valley Governorate, Egypt, had skin diseases, affecting their productivity and income.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.